Professional Title Gen Z Faces Diminishing Returns on Higher Education Amid Broader Economic Instability Samsung Chip Workers Potential Bonus Reaches 432000 Average Under Tentative Strike Agreement Broadcom Meta and Industry Leaders Launch 125 Million Semiconductor Research Hub at UCLA Dan Loebs Third Point Takes New Stake in Hut 8 Signaling Confidence in Bitcoin Mining Sector TQQQs TripleLeveraged Structure Led to 81 Loss in 2022 While Nasdaq Fell 33 Kevin Warsh Sworn In as Fed Chair at White House Pledges ReformOriented Approach SemiLEDS LEDS Q1 2026 Earnings Narrowing Loss Amid Operational Challenges Stock Jumps 1268 SCLX Q1 2026 Earnings Net Loss Widens as Pipeline Progress Drives Stock Higher HWC Q1 2026 Earnings Marginal EPS Surprise as Stock Edges Lower GTEC Q4 2025 Earnings Significant EPS Miss Despite Slight Stock Uptick BAER Q1 2026 Earnings EPS Misses by Over 50 But Stock Gains on Operational Progress NAUT Q1 2026 Earnings Narrowed Losses Beat Estimates Amid Platform Progress UTime Limited WTO Retreats to 108 as Selling Pressure Intensifies GRI Bio Inc GRI Slides 7 as Shares Test Key Support at 196 PIMCO Access Income Fund PAXS Nears Key Support as Price Dips Slightly Phibro Animal Health PAHC Gains 126 as Stock Approaches Key Resistance Level Bold Eagle Acquisition Corp BEAG Inches Up Amid Stable SPAC Trading GTY Q1 2026 Earnings Strong EPS Surprise Drives Modest Stock Uptick Brilliant Earth Group Inc BRLT Q1 2026 Earnings EPS Misses Estimates as Stock Rises on Operational Progress SYF Q1 2026 Earnings EPS Beat Highlights Resilient Consumer Credit Performance Lennar Corporation Q1 2026 Earnings EPS Misses Estimates Amid Housing Market Headwinds Dragonfly Energy Q1 2026 Earnings Earnings Miss Estimates Amid Challenging Quarter Cerence Inc CRNC Q1 2026 Earnings EPS Beat Slightly Offsets Market Skepticism Indian States Face Prolonged Fiscal Squeeze as Welfare Costs Outpace Revenue Growth Morgan Stanley QuinStreet QNST Q1 2026 Earnings EPS Misses Estimates Slightly Stock Gains on Operational Resilience Kiniksa Pharmaceuticals Holds Steady Near 54 as Stock Tests Key Resistance Levels